Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

By afschroeder • June 25, 2025

LeVee A, Peluso E, Lechner MG, Ruel N, Mortimer J, Kang I, Tsai K. Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer. Oncologist. 2025 Jun 4;30(6):oyaf134. doi: 10.1093/oncolo/oyaf134. PMID: 40549044.

Tags: breast cancer, Denosumab, Endocrinology, immune-related adverse events, immunotherapy, pembrolizumab, Publications

Developing and Evaluating a Natural Language Processing Algorithm to Detect Insulin Pump and Continuous Glucose Monitor Use in Electronic Health Records of Patients with Type 1 Diabetes

Everett E, Tiu RA, Zhu B, Feng J, Jackson N, Graham J, Ipp E, Mathioudakis N, Bui AAT, Moin T. Developing and Evaluating a Natural[...]

A Case of Warthin-Like Variant of Papillary Thyroid Cancer

Chow A, Laklouk I. A Case of Warthin-Like Variant of Papillary Thyroid Cancer. Cureus. 2025 Aug 28;17(8):e91182. doi: 10.7759/cureus.91182. PMID: 41018445; PMCID: PMC12476197.

Conventional Tobacco and Electronic Cigarettes Differentially Affect Cardiovascular Health in Male and Female Mice

Lao CJ, Jordan MC, Rivera JC, Tintut Y, Luna K, Ramirez-Trillo W, Yamamoto T, Pandit B, Huang C, Li A, Wang SL, Nguyen T, Castro[...]